Adjuvant Metformin in Type 1 Diabetes
This study is the first retrospective, long-term analysis of metformin as adjuvant therapy to insulin in patients with T1DM.
GLP-1 Agonists: Beneficial in Low-Risk Patients?
Do low-risk CVD patients with T2DM experience the same significantly lower all-cause and CV mortality seen in high-risk patients?
Bone Mineral Density in 50+ Years of Diabetes
A small pilot study is the first to report on bone health in people with an at least 50-year history of type 1 diabetes.
Evaluate Cardiometabolic Risk in Youth
How well do waist-to-height ratios calculated using NHANES and WHO protocols indicate cardiometabolic risk in youth with diabetes?
COPD--Impact of Undertreated Symptoms
A new study reports the impact on work productivity and lifestyle of undertreated COPD in the US, Europe, and China.
Top 8 Endocrinology Apps
Eight top apps for endocrinologists include decision support tools, printable patient handouts, calculators, and treatment guidelines.
Glycemic Control: CGM vs Self-Monitoring
The study also compared psychosocial variables, including treatment satisfaction, well-being, and fear of hypoglycemia, during CGM vs self-monitoring.
Intentional Eating: CV Health & Obesity
The American Heart Association released a statement about the impact meal timing and frequency has on cardiometabolic health and obesity.
Updated 2017 GOLD Recommendations for COPD
Important revisions to the GOLD recommendations include a new definition of COPD and refined diagnostic categories.
High Baseline CRP Predicts Mortality in COPD, Study Says
There are no optimal markers to predict mortality in COPD but results of a new study support further investigation of CRP.
By clicking Accept, you agree to become a member of the UBM Medica Community.